Steven Romick - First Pacific Advisors,
Holding/activity history for Bio-Rad Laboratories Inc. (BIO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 407,358 | 1.62 | Add 1.47% | 0.02 | $278.75 | $113,551,043 | SEC |
| 2025 Q4 | 401,457 | 1.63 | Add 1.79% | 0.03 | $302.99 | $121,637,456 | SEC |
| 2025 Q3 | 394,414 | 1.55 | Add 1.93% | 0.03 | $280.39 | $110,589,741 | SEC |
| 2025 Q2 | 386,949 | 1.36 | Add 3.86% | 0.05 | $241.32 | $93,378,533 | SEC |
| 2025 Q1 | 372,555 | 1.47 | Add 136.02% | 0.85 | $243.56 | $90,739,496 | SEC |
| 2024 Q4 | 157,850 | 0.75 | Reduce 0.02% | <0.01 | $328.51 | $51,855,304 | SEC |
| 2024 Q3 | 157,877 | 0.75 | Reduce 1.67% | 0.01 | $334.58 | $52,822,487 | SEC |
| 2024 Q2 | 160,552 | 0.60 | Add 53.29% | 0.21 | $273.11 | $43,848,357 | SEC |
| 2024 Q1 | 104,739 | 0.52 | Add 2,052.47% | 0.50 | $345.87 | $36,226,078 | SEC |
| 2023 Q4 | 4,866 | 0.02 | Buy | 0.02 | $322.89 | $1,571,183 | SEC |
| 2015 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2015 Q3 | 1,500 | <0.01 | $134.00 | $201,000 | SEC | ||
| 2015 Q2 | 1,500 | <0.01 | Reduce 99.32% | 0.25 | $150.67 | $226,000 | SEC |
| 2015 Q1 | 220,200 | 0.25 | Reduce 2.31% | <0.01 | $135.18 | $29,767,000 | SEC |
| 2014 Q4 | 225,400 | 0.22 | $120.56 | $27,174,000 | SEC | ||
| 2014 Q3 | 225,400 | 0.22 | $113.40 | $25,560,000 | SEC | ||
| 2014 Q2 | 225,400 | 0.23 | $119.71 | $26,983,000 | SEC | ||
| 2014 Q1 | 225,400 | 0.26 | Reduce 1.27% | <0.01 | $128.12 | $28,878,000 | SEC |
| 2013 Q4 | 228,300 | 0.27 | Reduce 24.83% | 0.09 | $123.61 | $28,220,000 | SEC |
| 2013 Q3 | 303,700 | 0.38 | Reduce 0.20% | <0.01 | $117.56 | $35,703,000 | SEC |
| 2013 Q2 | 304,300 | 0.38 | Reduce 0.75% | <0.01 | $112.20 | $34,142,000 | SEC |
| 2013 Q1 | 306,600 | 0.43 | Add 0.39% | <0.01 | $126.00 | $38,632,000 | SEC |
| 2012 Q4 | 305,400 | 0.40 | Reduce 0.65% | <0.01 | $105.05 | $32,082,000 | SEC |
| 2012 Q3 | 307,400 | 0.42 | $106.72 | $32,805,000 | SEC | ||
| 2012 Q2 | 307,400 | 0.40 | Reduce 7.27% | 0.04 | $100.01 | $30,743,000 | SEC |
| 2012 Q1 | 331,500 | 0.49 | Reduce 0.24% | <0.01 | $103.69 | $34,373,000 | SEC |
| 2011 Q4 | 332,300 | 0.49 | Reduce 5.84% | 0.03 | $96.04 | $31,914,000 | SEC |
| 2011 Q3 | 352,900 | 0.58 | Reduce 4.44% | 0.03 | $90.77 | $32,033,000 | SEC |
| 2011 Q2 | 369,300 | 0.73 | Reduce 0.70% | <0.01 | $119.36 | $44,080,000 | SEC |
| 2011 Q1 | 371,900 | 1.01 | Add 0.40% | <0.01 | $120.14 | $44,680,000 | SEC |
| 2010 Q4 | 370,400 | 1.03 | Reduce 1.75% | 0.02 | $103.85 | $38,466,000 | SEC |
| 2010 Q3 | 377,000 | 1.08 | Reduce 0.24% | <0.01 | $90.51 | $34,122,000 | SEC |
| 2010 Q2 | 377,900 | 1.31 | Add 7.08% | 0.09 | $86.49 | $32,685,000 | SEC |
| 2010 Q1 | 352,900 | 1.28 | Reduce 0.79% | <0.01 | $103.52 | $36,532,000 | SEC |
| 2009 Q4 | 355,700 | 1.02 | Reduce 1.22% | 0.01 | $96.46 | $34,311,000 | SEC |
| 2009 Q3 | 360,100 | 1.11 | Reduce 0.50% | <0.01 | $91.88 | $33,086,000 | SEC |
| 2009 Q2 | 361,900 | 1.10 | Add 0.03% | <0.01 | $75.48 | $27,316,000 | SEC |
| 2009 Q1 | 361,800 | 1.19 | Reduce 0.66% | <0.01 | $65.90 | $23,843,000 | SEC |
| 2008 Q4 | 364,200 | 1.23 | Reduce 0.84% | 0.01 | $75.31 | $27,428,000 | SEC |
| 2008 Q3 | 367,300 | 1.22 | Reduce 4.07% | 0.04 | $99.12 | $36,407,000 | SEC |
| 2008 Q2 | 382,900 | 0.92 | Reduce 1.90% | 0.02 | $80.89 | $30,973,000 | SEC |
| 2008 Q1 | 390,300 | 1.02 | Reduce 4.08% | 0.05 | $88.95 | $34,717,000 | SEC |
| 2007 Q4 | 406,900 | 1.18 | Reduce 2.77% | 0.03 | $103.62 | $42,163,000 | SEC |
| 2007 Q3 | 418,500 | 0.97 | Reduce 5.66% | 0.04 | $90.50 | $37,875,000 | SEC |
| 2007 Q2 | 443,600 | 0.77 | Reduce 4.31% | 0.03 | $75.57 | $33,523,000 | SEC |
| 2007 Q1 | 463,600 | 0.75 | Reduce 3.28% | 0.03 | $69.84 | $32,378,000 | SEC |
| 2006 Q4 | 479,300 | 0.93 | $82.52 | $39,552,000 | SEC |